Anti-DIK2B/ DIPK2B/ 4930578C19Rik functional antibody

Anti-DIK2B/ DIPK2B/ 4930578C19Rik functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to DIPK2B/DIPK2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0887-Ab-1/ GM-Tg-hg-SE0887-Ab-2Anti-Human DIPK2B monoclonal antibodyHuman
GM-Tg-rg-SE0887-Ab-1/ GM-Tg-rg-SE0887-Ab-2Anti-Rat DIPK2B monoclonal antibodyRat
GM-Tg-mg-SE0887-Ab-1/ GM-Tg-mg-SE0887-Ab-2Anti-Mouse DIPK2B monoclonal antibodyMouse
GM-Tg-cynog-SE0887-Ab-1/ GM-Tg-cynog-SE0887-Ab-2Anti-Cynomolgus/ Rhesus macaque DIPK2B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0887-Ab-1/ GM-Tg-felg-SE0887-Ab-2Anti-Feline DIPK2B monoclonal antibodyFeline
GM-Tg-cang-SE0887-Ab-1/ GM-Tg-cang-SE0887-Ab-2Anti-Canine DIPK2B monoclonal antibodyCanine
GM-Tg-bovg-SE0887-Ab-1/ GM-Tg-bovg-SE0887-Ab-2Anti-Bovine DIPK2B monoclonal antibodyBovine
GM-Tg-equg-SE0887-Ab-1/ GM-Tg-equg-SE0887-Ab-2Anti-Equine DIPK2B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0887-Ab-1/ GM-Tg-hg-SE0887-Ab-2; GM-Tg-rg-SE0887-Ab-1/ GM-Tg-rg-SE0887-Ab-2;
GM-Tg-mg-SE0887-Ab-1/ GM-Tg-mg-SE0887-Ab-2; GM-Tg-cynog-SE0887-Ab-1/ GM-Tg-cynog-SE0887-Ab-2;
GM-Tg-felg-SE0887-Ab-1/ GM-Tg-felg-SE0887-Ab-2; GM-Tg-cang-SE0887-Ab-1/ GM-Tg-cang-SE0887-Ab-2;
GM-Tg-bovg-SE0887-Ab-1/ GM-Tg-bovg-SE0887-Ab-2; GM-Tg-equg-SE0887-Ab-1/ GM-Tg-equg-SE0887-Ab-2
Products NameAnti-DIPK2B monoclonal antibody
Formatmab
Target NameDIPK2B
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-DIPK2B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0887-Ag-1Recombinant multi-species DIK2B/ DIPK2B/ 4930578C19Rik protein


    Target information

    Target IDGM-SE0887
    Target NameDIPK2B
    Gene ID79742,75905,501512,709814,612457,101092998,617391,100050952
    Gene Symbol and Synonyms4930578C19Rik,bA435K1.1,CXHXorf36,CXorf36,DIA1R,DIPK2B,EPQL1862,PRO3743,RGD1559731
    Uniprot AccessionQ9H7Y0,Q58CX7
    Uniprot Entry NameDIK2B_HUMAN,DIK2B_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000147113
    Target ClassificationN/A

    The target: DIPK2B, gene name: DIPK2B, also named as 4930578C19Rik, CXorf36, DIA1R, EPQL1862, PRO3743, bA435K1.1. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.